Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MSVEX vs. BKUI: which is better?

Bottom line

MSVEX vs BKUI: the short answer

MSVEX (Vitality Portfolio) and BKUI (BNY Mellon Ultra Short Income ETF) are both mutual funds.

BKUI is cheaper at 0.12% vs 1.3% — a difference of $118 a year per $10,000 invested.

Over one year, MSVEX returned +8.7% vs +5.0% for BKUI.

MSVEX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

MSVEX vs BKUI side by side

MSVEXBKUI
TypeMutual fundETF
Fund familyMorgan StanleyBNY Mellon / Dreyfus
CategoryOtherOther
Expense ratio1.3%0.12%
Annual cost per $10k$130$12
10-yr cost on $10k (prospectus)$10,017$154
Max front load5.25%None
12b-1 fee0.25%0%
1-yr return+8.7%+5.0%
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter—+2.0%
Worst quarter—−1.0%
Net assets (fund)—$574.7M
Number of holdings—157
Portfolio turnover27%14%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MSVEX and BKUI share none of their top holdings.

MSVEX top 10

    BKUI top 10

    1. Dnb Bank Asa — 2.86%
    2. Credit Industriel Et Commercial-cic Sa New York Branch — 2.61%
    3. Banco Santander Sa — 2.52%
    4. Norddeutsche Lan 0627 — 2.51%
    5. Societe Generale North America Inc — 2.14%
    6. Banco Bilbao Vizcaya Argentaria Sa — 2.10%
    7. Westpac Banking Corp — 2.10%
    8. Abn Amro Funding USA Llc — 2.07%
    9. Old Line Funding LLC — 2.05%
    10. Manhattan Asset Funding Company LLC — 1.74%

    FAQ

    What is the difference between MSVEX and BKUI?
    MSVEX (Vitality Portfolio) and BKUI (BNY Mellon Ultra Short Income ETF) are both mutual funds. BKUI is cheaper at 0.12% vs 1.3% — a difference of $118 a year per $10,000 invested.
    Which is cheaper, MSVEX or BKUI?
    BKUI has the lower expense ratio (0.12%).
    Should I own both MSVEX and BKUI?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.